Skip to main content
. 2009 Sep 25;284(47):32742–32749. doi: 10.1074/jbc.M109.047910

FIGURE 1.

FIGURE 1.

A, AlbCre-mediated knockdown of floxed PERK (AlbCre+, PERKfl/fl) in liver (Liv) but not pancreas (Pan), spleen (Spl), or tail of GCN2+/+ and GCN2−/− mice (upper panel). GCN2 was deleted in the liver, pancreas, and spleen of GCN2−/−-AlbCre+-PERKfl/fl mice but not GCN2+/+-AlbCre+-PERKfl/fl mice (lower panel). WT, wild type; KO, knock-out. B, asparaginase increased phosphorylation of eIF2 in the liver of both wild-type (GCN2+/+-AlbCre-PERKfl/fl) and PERK knockdown (GCN2+/+-AlbCre+-PERKfl/fl) mice. Means not sharing same lowercase letter are different from each other (by one-way ANOVA), p < 0.05. C, phosphorylation of eIF2 is reduced in the liver of GCN2 null mice both with and without AlbCre-mediated PERK knockdown following asparaginase injection. **, main effect of asparaginase to increase p-eIF2 (by two-way ANOVA), p < 0.05. D, hepatic ASNS mRNA expression was not significantly increased following asparaginase treatment in GCN2 null mice with or without AlbCre-mediated deletion of floxed PERK in liver. Abbreviations: S, saline; A, asparaginase.